DocuSign, Inc. (Nasdaq: DOCU), a renowned provider of electronic signature technology and digital transaction management services, reported its first-quarter fiscal 2024 financial results. The company exceeded expectations with adjusted earnings per share (EPS) of $0.72, beating the consensus estimate of $0.56.

DocuSign also provided its revenue guidance for the second quarter, expecting it to be in the range of $675 million to $679 million, surpassing the consensus estimate of $670.37 million. 

$DOCU is trading at $61.01 in after-hours, reflecting a notable increase of $2.53  (+4.33%)

ContraFect Corporation (Nasdaq: CFRX), a company dedicated to combating drug-resistant infections, has also made significant strides. The company announced its participation in the upcoming ASM Microbe Conference to be held in Houston, Texas from June 15-19, 2023. 

At the conference, ContraFect will present four posters showcasing the efficacy of CF-370, their innovative product, in a neutropenic rabbit pneumonia model against an extensively drug-resistant (XDR) strain of Klebsiella pneumoniae (K. pneumoniae).

The anticipation surrounding ContraFect's presentations has resulted in a substantial market response. In after-hours, $CFRX is currently trading at $2.39, representing a remarkable increase of $0.95  (+65.97%).

Uber Technologies, Inc. (NYSE: UBER), a prominent ride-hailing and food delivery company, has been initiated with an Overweight rating and a price target of $50 by Wells Fargo. 

$UBER closed at $40.26 on Thursday, indicating a potential upside of $9.74 or 24.17% based on Wells Fargo's analysis.

Lufax Holding Ltd. (NYSE: LU), a prominent technology-driven personal financial services platform, has received an Outperform rating and a price target of $2.50 from Bernstein. 

With $LU closing at $1.59 on Thursday, the price target implies a potential upside of $0.91 or 57.23%, as per Bernstein's evaluation.

These price targets and potential upsides are derived from the analysis and projections of Wells Fargo and Bernstein, respectively, and serve as a reflection of their outlook on the companies. Investors and market participants should carefully consider these opinions and conduct their own research before making any investment decisions.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)